| Claudia Jade Anderson, PHARMD | |
|
2121 Sw Fairlawn Rd, Topeka, KS 66614-1501 | |
| (785) 273-1050 | |
| Not Available |
| Full Name | Claudia Jade Anderson |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2121 Sw Fairlawn Rd, Topeka, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396517272 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-109559 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Claudia Jade Anderson, PHARMD 1908 Barker Ave, Lawrence, KS 66046-3138 Ph: () - | Claudia Jade Anderson, PHARMD 2121 Sw Fairlawn Rd, Topeka, KS 66614-1501 Ph: (785) 273-1050 |
News Archive
Initiatives aimed at cutting the number of errors made when prescribing medicines to children are the focus of a project being led by researchers at The University of Nottingham and The School of Pharmacy, University of London.
Consumer Watchdog called on the Obama Administration and the Department of Health and Human Services today to probe insurance giant WellPoint Inc. in light of an electronic message to investors describing how it would simply re-label administrative costs as "medical care" in response to the new health reform law. The message follows revelations that WellPoint, parent company of Anthem Blue Cross, also intentionally padded already huge premium increases in California, just in case regulators demanded reductions.
Runners taking part in the April 2010 London Marathon can boost their recovery time by drinking tart cherry juice before and after the race, according to a researcher at Northumbria University.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted the 12-month results of the OrBIT Trial of its Urgent® PC Neuromodulation System that will be published in the January 2010 print edition of THE JOURNAL OF UROLOGY®.
Barr Pharmaceuticals has announced that Gedeon Richter, Plc. has received final U.S. Food & Drug Administration (FDA) approval for its application to manufacture and market a generic version of Novartis Pharmaceutical Corporation's LAMISIL (terbinafine hydrochloride) Tablets, 250 mg. The approval follows the expiration of pediatric exclusivity for LAMISIL.
› Verified 9 days ago
Mr. Gary Kluczykowski, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1740 Sw Wanamaker Rd, Topeka, KS 66604 Phone: 785-273-4040 | |
Josh Lock, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2010 Se 29th St, Topeka, KS 66605 Phone: 785-267-0234 Fax: 785-274-0221 | |
Joshua Schmidt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 Sw 7th St, Topeka, KS 66606 Phone: 785-295-8050 | |
Patrick Budenbender Ii, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2951 Sw Wanamaker Rd, Topeka, KS 66614 Phone: 785-271-0764 | |
Cara M Clingenpeel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw Gage Blvd, Topeka, KS 66622 Phone: 785-350-3111 Fax: 785-350-4520 | |
Chris Kneidel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 121 Se 6th Ave, Topeka, KS 66603 Phone: 877-232-4601 | |
Gregory Mccandless Gage Russell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3900 Sw 29th St, Topeka, KS 66614 Phone: 785-271-9981 |